CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Motlalepula Matsabisa - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Motlalepula Matsabisa

OPENALEX: A5046581101↗ORCID: 0000-0003-2921-8882↗

Affiliations

Organizations

University of the Free Stateauthorship · ZA

Public evidence

5 connected articles

In silico investigation of cannabinoids from <i>Cannabis sativa</i> leaves as a potential anticancer drug to inhibit MAPK-ERK signaling pathway and EMT induction.2024 · Europe PMC Targeting of Protein's Messenger RNA for Viral Replication, Assembly and Release in SARS-CoV-2 Using Whole Genomic Data From South Africa: Therapeutic Potentials of <i>Cannabis Sativa</i> L.2021 · Europe PMC <i>Cannabis sativa</i> L. (var. <i>indica</i>) Exhibits Hepatoprotective Effects by Modulating Hepatic Lipid Profile and Mitigating Gluconeogenesis and Cholinergic Dysfunction in Oxidative Hepatic Injury.2021 · Europe PMC Tetrahydrocannabinol-Rich Extracts From <i>Cannabis Sativa</i> L. Improve Glucose Consumption and Modulate Metabolic Complications Linked to Neurodegenerative Diseases in Isolated Rat Brains.2020 · Europe PMC Priority areas for cannabis and cannabinoid product research in South Africa.2018 · Europe PMC

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.